Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Hiroaki Wakimoto, Ph.D., M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Hiroaki Wakimoto and Dora Dias-Santagata.
Hiroaki Wakimoto
Connection Strength
0.194
Dora Dias-Santagata
  1. Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas. Clin Cancer Res. 2014 Jun 01; 20(11):2898-909.
    View in: PubMed
    Score: 0.143
  2. PI3K/AKT/mTOR Pathway Alterations Promote Malignant Progression and Xenograft Formation in Oligodendroglial Tumors. Clin Cancer Res. 2019 07 15; 25(14):4375-4387.
    View in: PubMed
    Score: 0.051
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.